Literature DB >> 22298641

Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells.

Xiuzhen Han1, Baoshan Xu, Christopher S Beevers, Yoshinobu Odaka, Long Chen, Lei Liu, Yan Luo, Hongyu Zhou, Wenxing Chen, Tao Shen, Shile Huang.   

Abstract

Curcumin can induce p53-independent apoptosis. However, the underlying mechanism remains to be defined. Here, we show that curcumin-induced apoptosis in a panel of tumor cells with mutant p53. Curcumin rapidly induced activation of the mitogen-activated protein kinases (MAPKs) including extracellular signal-regulated kinase 1/2 (Erk1/2) and c-Jun N-terminal kinase (JNK). Inhibition of JNK (with SP600125) or Erk1/2 (with U0126) partially prevented curcumin-induced cell death in the cells. Similarly, expression of dominant negative c-Jun or downregulation of Erk1/2 in part attenuated curcumin-induced cell death. It appears that curcumin-induced activation of MAPKs and apoptosis was due to induction of reactive oxygen species (ROS), as pretreatment with N-acetyl-L-cysteine, a ROS scavenger, blocked these events. Furthermore, we found that curcumin-induced activation of MAPK pathways was related to inhibition of the serine/threonine protein phosphatases 2A (PP2A) and 5 (PP5). Overexpression of PP2A or PP5 partially prevented curcumin-induced activation of JNK and Erk1/2 phosphorylation as well as cell death. The results suggest that curcumin induction of ROS activates MAPKs, at least partially by inhibiting PP2A and PP5, thereby leading to p53-independent apoptosis in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22298641      PMCID: PMC3324444          DOI: 10.1093/carcin/bgs029

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  55 in total

1.  Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation.

Authors:  Asok Mukhopadhyay; Sanjeev Banerjee; Lewis Joe Stafford; Chunzhi Xia; Mingyao Liu; Bharat B Aggarwal
Journal:  Oncogene       Date:  2002-12-12       Impact factor: 9.867

2.  Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.

Authors:  J A Bush; K J Cheung; G Li
Journal:  Exp Cell Res       Date:  2001-12-10       Impact factor: 3.905

3.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Authors:  A L Cheng; C H Hsu; J K Lin; M M Hsu; Y F Ho; T S Shen; J Y Ko; J T Lin; B R Lin; W Ming-Shiang; H S Yu; S H Jee; G S Chen; T M Chen; C A Chen; M K Lai; Y S Pu; M H Pan; Y J Wang; C C Tsai; C Y Hsieh
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

4.  Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells.

Authors:  Lala R Chaudhary; Keith A Hruska
Journal:  J Cell Biochem       Date:  2003-05-01       Impact factor: 4.429

5.  Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress.

Authors:  K Morita; M Saitoh; K Tobiume; H Matsuura; S Enomoto; H Nishitoh; H Ichijo
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

6.  Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells.

Authors:  Jia-Ching Wu; Ching-Shu Lai; Vladimir Badmaev; Kalyanam Nagabhushanam; Chi-Tang Ho; Min-Hsiung Pan
Journal:  Mol Nutr Food Res       Date:  2011-09-19       Impact factor: 5.914

Review 7.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

Authors:  V Janssens; J Goris
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

8.  Impairment of phosphatase 2A contributes to the prolonged MAP kinase phosphorylation in Alzheimer's disease fibroblasts.

Authors:  Wei-Qin Zhao; Christina Feng; Daniel L Alkon
Journal:  Neurobiol Dis       Date:  2003-12       Impact factor: 5.996

9.  Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1).

Authors:  Shile Huang; Lili Shu; Michael B Dilling; John Easton; Franklin C Harwood; Hidenori Ichijo; Peter J Houghton
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

10.  Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.

Authors:  Ju-Hyung Woo; Young-Ho Kim; Yun-Jung Choi; Dae-Gon Kim; Kyung-Seop Lee; Jae Hoon Bae; Do Sik Min; Jong-Soo Chang; Yong-Jin Jeong; Young Han Lee; Jong-Wook Park; Taeg Kyu Kwon
Journal:  Carcinogenesis       Date:  2003-05-09       Impact factor: 4.944

View more
  34 in total

1.  Oxidative stress parameters in blood, liver, and kidney of diabetic rats treated with curcumin and/or insulin.

Authors:  Heloisa Einloft Palma; Patrícia Wolkmer; Miguel Gallio; Marcos M B Corrêa; Roberta Schmatz; Gustavo R Thomé; Luciane B Pereira; Verônica S P Castro; Andréia B Pereira; Andressa Bueno; Lizielle S de Oliveira; Debora Rosolen; Thaís R Mann; Bianca S de Cecco; Dominguita L Graça; Sonia T A Lopes; Cinthia M A Mazzanti
Journal:  Mol Cell Biochem       Date:  2013-10-16       Impact factor: 3.396

Review 2.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

3.  A novel spiroindoline targets cell cycle and migration via modulation of microtubule cytoskeleton.

Authors:  Naveen Kumar; Santanu Hati; Parthapratim Munshi; Subhabrata Sen; Seema Sehrawat; Shailja Singh
Journal:  Mol Cell Biochem       Date:  2017-02-17       Impact factor: 3.396

4.  c-Myc modulation: a key role in melanoma drug response.

Authors:  Annalisa Fico; Daniela Alfano; Anna Valentino; Valeria Vasta; Ernesta Cavalcanti; Salvatore Travali; Eduardo J Patriarca; Emilia Caputo
Journal:  Cancer Biol Ther       Date:  2015-04-02       Impact factor: 4.742

5.  Sanguinarine inhibits the proliferation of BGC-823 gastric cancer cells via regulating miR-96-5p/miR-29c-3p and the MAPK/JNK signaling pathway.

Authors:  Xian-Zhe Dong; Yan Song; Yu-Pan Lu; Yuan Hu; Ping Liu; Lan Zhang
Journal:  J Nat Med       Date:  2019-06-26       Impact factor: 2.343

6.  Multiple effects of curcumin on promoting expression of the exon 7-containing SMN2 transcript.

Authors:  Dairong Feng; Yi Cheng; Yan Meng; Liping Zou; Shangzhi Huang; Jiuyong Xie
Journal:  Genes Nutr       Date:  2015-09-19       Impact factor: 5.523

7.  Rapamycin ameliorates cadmium-induced activation of MAPK pathway and neuronal apoptosis by preventing mitochondrial ROS inactivation of PP2A.

Authors:  Chong Xu; Xiaoxue Wang; Yu Zhu; Xiaoqing Dong; Chunxiao Liu; Hai Zhang; Lei Liu; Shile Huang; Long Chen
Journal:  Neuropharmacology       Date:  2016-01-22       Impact factor: 5.250

8.  Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells.

Authors:  Yoshinobu Odaka; Baoshan Xu; Yan Luo; Tao Shen; Chaowei Shang; Yang Wu; Hongyu Zhou; Shile Huang
Journal:  Carcinogenesis       Date:  2013-08-08       Impact factor: 4.944

9.  BAFF activates Erk1/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells.

Authors:  Dingfang Liang; Qingyu Zeng; Zhigang Xu; Hai Zhang; Lin Gui; Chong Xu; Sujuan Chen; Shuangquan Zhang; Shile Huang; Long Chen
Journal:  Biochem Pharmacol       Date:  2013-11-22       Impact factor: 5.858

10.  (E)-2,4-bis(p-hydroxyphenyl)-2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-κB and up-regulation of TNFRSF10B (DR5).

Authors:  Pushpa Saranya Kollipara; Heon Sang Jeong; Sang Bae Han; Jin Tae Hong
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.